Difficulty: Medium
Average Score: 91%
Practice
Pulmonary hypotension in a neonate associate with
Correct answer
A
Rationale
In a neonate, pulmonary hypotension is often associated with diaphragmatic hernia. The diaphragmatic hernia leads to a defect in the diaphragm, allowing abdominal organs to move into the chest cavity, compressing the lungs and interfering with their development. This can result in pulmonary hypotension due to compromised lung function.
Option B, oxygen therapy, is commonly used to treat respiratory conditions but is not directly associated with causing pulmonary hypotension in a neonate. Meconium aspiration (Option C) can lead to respiratory distress syndrome but not necessarily pulmonary hypotension. Pneumothorax (Option D) is the presence of air in the pleural space and can cause respiratory distress, but it is not a direct cause of pulmonary hypotension in neonates.
Understanding the link between diaphragmatic hernia and pulmonary hypotension in neonates is crucial for nurses and healthcare providers caring for pediatric patients. Recognizing this association can lead to early detection and appropriate management, improving outcomes for these vulnerable infants. It highlights the importance of a comprehensive understanding of pediatric pharmacology and conditions affecting the cardiovascular system in neonates.
Option B, oxygen therapy, is commonly used to treat respiratory conditions but is not directly associated with causing pulmonary hypotension in a neonate. Meconium aspiration (Option C) can lead to respiratory distress syndrome but not necessarily pulmonary hypotension. Pneumothorax (Option D) is the presence of air in the pleural space and can cause respiratory distress, but it is not a direct cause of pulmonary hypotension in neonates.
Understanding the link between diaphragmatic hernia and pulmonary hypotension in neonates is crucial for nurses and healthcare providers caring for pediatric patients. Recognizing this association can lead to early detection and appropriate management, improving outcomes for these vulnerable infants. It highlights the importance of a comprehensive understanding of pediatric pharmacology and conditions affecting the cardiovascular system in neonates.